Our study initiated to explore the relationship between blood lipids and cognitive impairment in patients with T2DM, we found that increased serum apolipoprotein A1 levels were significantly  associated with cognitive impairment in patients with T2DM. Here, APOA1 is linked to Cognitive impairment.